← back to search

Roger L. Milne

Monash Institute of Medical Research · AU
Area of research
Genetics · Epidemiology
Research interest
Research interests include Adipokines, Inflammation, and Metabolic Diseases, BRCA gene mutations in cancer, Cancer Risks and Factors, and Genetic Associations and Epidemiology.
h-index
107
citations
57,415
works
1,395
NIH funding
primary concept
email

Recent publications

Alcohol intake and pancreatic cancer risk: An analysis from 30 prospective studies across Asia, Australia, Europe, and North America
PLoS Medicine 2025cited by 22position: middledoi
Exogenous Hormones, Tumor Intrinsic Subtypes, and Breast Cancer
JAMA Network Open 2025cited by 8position: middledoi
Hormone therapy use and young-onset breast cancer: a pooled analysis of prospective cohorts included in the Premenopausal Breast Cancer Collaborative Group
The Lancet Oncology 2025cited by 8position: middledoi
Analysis of more than 400,000 women provides case-control evidence for BRCA1 and BRCA2 variant classification
Nature Communications 2025cited by 7position: middledoi
Association between socioeconomic position and lung cancer incidence in 16 countries: a prospective cohort consortium study
EClinicalMedicine 2025cited by 6position: middledoi
Development and validation of a risk prediction model for premenopausal breast cancer in 19 cohorts
Breast Cancer Research 2025cited by 1position: middledoi
Large-scale meta-analysis and precision functional assays identify FANCM regions in which PTVs confer different risks for ER-negative and triple-negative breast cancer
The Breast 2025cited by 1position: middledoi
Mammographic density, pathogenic breast cancer susceptibility gene variants and breast cancer risk
medRxiv 2025cited by 0position: middledoi
Hormonal Contraception and Breast Cancer Risk for Carriers of Germline Mutations in <i>BRCA1</i> and <i>BRCA2</i>
Journal of Clinical Oncology 2024cited by 21position: middledoi
Physical Activity, Sedentary Behavior, and Pancreatic Cancer Risk: A Mendelian Randomization Study
Journal of the Endocrine Society 2024cited by 15position: middledoi
BMI and breast cancer risk around age at menopause
Cancer Epidemiology 2024cited by 11position: middledoi
Large-scale genome-wide association study of 398,238 women unveils seven novel loci associated with high-grade serous epithelial ovarian cancer risk
medRxiv 2024cited by 3position: middledoi
Analysis of more than 400,000 women provides case-control evidence for BRCA1 and BRCA2 variant classification
medRxiv 2024cited by 3position: middledoi
Genome-Wide Analysis to Assess if Heavy Alcohol Consumption Modifies the Association between SNPs and Pancreatic Cancer Risk
Cancer Epidemiology Biomarkers & Prevention 2024cited by 1position: middledoi
Analysis of variants in untranslated and promoter regions and breast cancer risk using whole genome sequencing data
medRxiv 2024cited by 1position: middledoi
The blood proteome of imminent lung cancer diagnosis
Nature Communications 2023cited by 74position: middledoi
Genome-wide Association Study of Bladder Cancer Reveals New Biological and Translational Insights
European Urology 2023cited by 71position: middledoi
Germline Sequencing Analysis to Inform Clinical Gene Panel Testing for Aggressive Prostate Cancer
JAMA Oncology 2023cited by 51position: middledoi
Epigenome-wide meta-analysis of BMI in nine cohorts: Examining the utility of epigenetically predicted BMI
The American Journal of Human Genetics 2023cited by 29position: middledoi
Prognostic role of detailed colorectal location and tumor molecular features: analyses of 13,101 colorectal cancer patients including 2994 early-onset cases
Journal of Gastroenterology 2023cited by 28position: middledoi
Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysis
JNCI Journal of the National Cancer Institute 2023cited by 25position: middledoi
Lung cancer risk discrimination of prediagnostic proteomics measurements compared with existing prediction tools
JNCI Journal of the National Cancer Institute 2023cited by 21position: middledoi
Associations of height, body mass index, and weight gain with breast cancer risk in carriers of a pathogenic variant in BRCA1 or BRCA2: the BRCA1 and BRCA2 Cohort Consortium
Breast Cancer Research 2023cited by 13position: middledoi
International Pooled Analysis of Leisure-Time Physical Activity and Premenopausal Breast Cancer in Women From 19 Cohorts
Journal of Clinical Oncology 2023cited by 10position: middledoi
Association of tea and coffee consumption and biliary tract cancer risk: The Biliary Tract Cancers Pooling Project
Hepatology 2023cited by 9position: middledoi
A Likelihood Ratio Approach for Utilizing Case-Control Data in the Clinical Classification of Rare Sequence Variants: Application to BRCA1 and BRCA2
Human Mutation 2023cited by 6position: middledoi
Leisure time television watching, computer use and risks of breast, colorectal and prostate cancer: A Mendelian randomisation analysis
Cancer Medicine 2023cited by 3position: middledoi
Spectrum and Frequency of Germline FANCM Protein-Truncating Variants in 44,803 European Female Breast Cancer Cases
Cancers 2023cited by 1position: middledoi
Correction: Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes
Leukemia 2023cited by 1position: middledoi
Leisure time sedentary behaviour and risks of breast, colorectal, and prostate cancer: A Mendelian randomization analysis
medRxiv 2023cited by 1position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Graham G. Giles · Monash Institute of Medical Research22 papers (2017–2021)John L. Hopper · National Institute on Deafness and Other Communication Disorders14 papers (2013–2022)Melissa C. Southey · Monash Health13 papers (2017–2020)Esther M. John · Palo Alto University9 papers (2013–2022)Gillian S. Dite · Columbia University8 papers (2018–2019)Irene L. Andrulis · University of Toronto7 papers (2013–2019)Mary Beth Terry · Columbia University Irving Medical Center7 papers (2018–2022)Robert J. MacInnis · Cancer Council Victoria7 papers (2017–2019)Saundra S. Buys · University of Utah7 papers (2013–2019)Mary B. Daly · Fox Chase Cancer Center7 papers (2013–2019)Wendy K. Chung · Oregon Health & Science University7 papers (2013–2019)Gord Glendon · Lunenfeld-Tanenbaum Research Institute6 papers (2018–2019)Daniel D. Buchanan · Morehouse College6 papers (2017–2022)Brigid M. Lynch · The University of Melbourne6 papers (2017–2024) · 6 papers (2018–2019)Julia A. Knight · Lunenfeld-Tanenbaum Research Institute6 papers (2018–2019) · 5 papers (2018–2019)Douglas F. Easton · Pacific Biomarkers (United States)5 papers (2019–2022)Ulrike Peters · Fred Hutch Cancer Center5 papers (2020–2023)Peter Kraft · National Cancer Institute5 papers (2017–2021)